NCT07193394
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07193394
Title Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer (H3RAKLES)
Acronym H3RAKLES
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Polyclinique Bordeaux Nord Aquitaine Bordeaux 33 300 France Details
Chu Dupuytren- Limoges Limoges 87 042 France Details
Institut Paoli-Calmettes Marseille 13009 France Details
Centre Antoine Lacassagne Nice 06 189 France Details
CHU de Nîmes Nîmes 30 029 France Details
Centre Eugène Marquis Rennes 35 042 France Details
Institut Curie_ Site Saint-Cloud Saint-Cloud 92 210 France Details
Institut Universitaire du Cancer de Toulouse (IUCT) - Oncopole Claudius Regaud Toulouse 31 059 France Details
Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy 54 519 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field